RE: Large trades....11 Apr 2019 11:27
I like this bit
In addition to the growth in our core services business, we were pleased to announce positive data for FLU-v, the late stage, broad spectrum universal influenza vaccine candidate in our joint venture Imutex. We continue to make progress regarding strategic discussions related to the assets in this JV, helping to maximise the strategic options available. We have had a number of positive discussions and we are continuing to explore a number of options to enable the continued development of the FLU-v vaccine.